47 related articles for article (PubMed ID: 36244446)
1. Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt/β-catenin signaling.
Ma X; Hu X; Zhu Y; Jin H; Hu G; Ding L; Ning S
Biochem Pharmacol; 2022 Dec; 206():115299. PubMed ID: 36244446
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/β-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer.
Shome R; Sen P; Sarkar S; Ghosh SS
Exp Cell Res; 2024 May; 438(1):114032. PubMed ID: 38583856
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
[TBL] [Abstract][Full Text] [Related]
4. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract][Full Text] [Related]
5. Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axis.
Cheng Z; Yu R; Li L; Mu J; Gong Y; Wu F; Liu Y; Zhou X; Zeng X; Wu Y; Sun R; Xiang T
Cell Mol Life Sci; 2022 May; 79(5):280. PubMed ID: 35507080
[TBL] [Abstract][Full Text] [Related]
6. CBX7 negatively regulates migration and invasion in glioma via Wnt/β-catenin pathway inactivation.
Bao Z; Xu X; Liu Y; Chao H; Lin C; Li Z; You Y; Liu N; Ji J
Oncotarget; 2017 Jun; 8(24):39048-39063. PubMed ID: 28388562
[TBL] [Abstract][Full Text] [Related]
7. Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway.
Tan Z; Boyapati K; Tressler CM; Jenkinson NM; Glunde K
Cancer Lett; 2024 Apr; 586():216653. PubMed ID: 38309615
[TBL] [Abstract][Full Text] [Related]
8. The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer.
Wang W; Rana PS; Markovic V; Sossey-Alaoui K
Breast Cancer Res; 2023 Mar; 25(1):31. PubMed ID: 36949468
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan suppresses proliferation and epithelial-mesenchymal transition process via Wnt/β-catenin signalling in hemangioma.
Zhu Z; Luo J; Li L; Wang D; Xu Q; Teng J; Zhou J; Sun L; Yu N; Zuo D
Exp Dermatol; 2024 Mar; 33(3):e15027. PubMed ID: 38514926
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde oxidase 1 promotes gallbladder carcinogenesis through ROS-mediated activation of the Wnt/β-catenin pathway.
Yuan Z; Yi G; Ma R; Wang Z; Hu J; Zhao W; Hu Y
Cell Signal; 2024 Apr; 116():111042. PubMed ID: 38199597
[TBL] [Abstract][Full Text] [Related]
11. 17β-Estradiol promotes metastasis in triple-negative breast cancer through the Calpain/YAP/β-catenin signaling axis.
Niu X; Wang J; Liu J; Yu Q; Ci M
PLoS One; 2024; 19(3):e0298184. PubMed ID: 38547301
[TBL] [Abstract][Full Text] [Related]
12. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
Ahn SY
BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
[TBL] [Abstract][Full Text] [Related]
13. Sesamol Induces Human Hepatocellular Carcinoma Cells Apoptosis by Impairing Mitochondrial Function and Suppressing Autophagy.
Liu Z; Ren B; Wang Y; Zou C; Qiao Q; Diao Z; Mi Y; Zhu D; Liu X
Sci Rep; 2017 Apr; 7():45728. PubMed ID: 28374807
[TBL] [Abstract][Full Text] [Related]
14. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer.
Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S
Cell Signal; 2024 Apr; 120():111196. PubMed ID: 38697448
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine inhibits the proliferation and metastasis of epithelial ovarian cancer through the Wnt/β-catenin pathway.
Sun M; Huang S; Gao Y
Transl Cancer Res; 2021 Jul; 10(7):3479-3490. PubMed ID: 35116652
[TBL] [Abstract][Full Text] [Related]
16. Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer.
Scully MA; Wilhelm R; Wilkins DE; Day ES
ACS Biomater Sci Eng; 2024 Mar; 10(3):1355-1363. PubMed ID: 38306303
[TBL] [Abstract][Full Text] [Related]
17. Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma.
Malyla V; De Rubis G; Paudel KR; Chellappan DK; Hansbro NG; Hansbro PM; Dua K
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3595-3603. PubMed ID: 37266589
[TBL] [Abstract][Full Text] [Related]
18. YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the β-catenin pathway.
Chen X; Lin X; Xia X; Xiang X
J Investig Med; 2024 Mar; ():10815589241239577. PubMed ID: 38441112
[TBL] [Abstract][Full Text] [Related]
19. NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer.
O'Neill KI; Kuo LW; Williams MM; Lind H; Crump LS; Hammond NG; Spoelstra NS; Caino MC; Richer JK
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884604
[TBL] [Abstract][Full Text] [Related]
20. RNA sequencing reveals the differential expression profiles of RNA in metastatic triple negative breast cancer and identifies SHISA3 as an efficient tumor suppressor gene.
Khaled N; Sonnier N; Molnar I; Ponelle-Chachuat F; Kossai M; Radosevic-Robin N; Privat M; Bidet Y
Am J Cancer Res; 2021; 11(9):4568-4581. PubMed ID: 34659906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
